FreeSlate claimed that it provides researchers with increased experimental capacity and faster decision-making via its microscale, high-throughput technology, lab execution and analysis software, and experienced engineers and application scientists.
FreeSlate owns portfolio of IP covering high-throughput, parallel and microscale technology. The company’s offerings include integrated workflow systems and product-related services such as technology development, feasibility demonstration, proof of concept, and managed services.
John Senaldi, CEO of FreeSlate and former president of the HPR business unit at Symyx, said: “R&D organiations are continually seeking to accelerate discovery and development while avoiding unnecessary expenses.
“At FreeSlate, we use our expertise to deploy proven high-throughput technology solutions, enabling step-change gains in productivity and innovation for these customers. Now as an independent company, we can maintain an even sharper focus on ensuring such results within the R&D labs of our broad, global customer base.”